Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug;20(8):808-14.
doi: 10.1016/j.parkreldis.2014.05.011. Epub 2014 Jun 3.

Differentiating drug-induced parkinsonism from Parkinson's disease: an update on non-motor symptoms and investigations

Affiliations
Free article
Review

Differentiating drug-induced parkinsonism from Parkinson's disease: an update on non-motor symptoms and investigations

Francesco Brigo et al. Parkinsonism Relat Disord. 2014 Aug.
Free article

Abstract

Drug-induced parkinsonism is the second most common cause of parkinsonism after Parkinson's disease and their distinction has crucial implications in terms of management and prognosis. However, differentiating between these conditions can be challenging on a clinical ground, especially in the early stages. We therefore performed a review to ascertain whether assessment of non-motor symptoms, or use of ancillary investigations, namely dopamine transporter imaging, transcranial sonography of the substantia nigra, and scintigraphy for myocardial sympathetic innervation, can be recommended to distinguish between these conditions. Among non-motor symptoms, there is evidence that hyposmia can differentiate between patients with "pure" drug-induced parkinsonism and those with degenerative parkinsonism unmasked by an anti-dopaminergic drug. However, several issues, including smoking history and cognitive functions, can influence smell function assessment. Higher diagnostic accuracy has been demonstrated for dopamine transporter imaging. Finally, preliminary evidence exists for sympathetic cardiac scintigraphy to predict dopaminergic pathway abnormalities and to differentiate between drug-induced parkinsonism and Parkinson's disease. Imaging of the dopaminergic pathway seems to be the only, reasonably available, technique to aid the differential diagnosis between drug-induced parkinsonism and Parkinson's disease.

Keywords: Differential diagnosis; Dopamine transporter imaging; Drug-induced parkinsonism; Non-motor symptoms; Parkinson's disease; Transcranial sonography of the substantia nigra.

PubMed Disclaimer

MeSH terms

LinkOut - more resources